LAVA Therapeutics NV (LVTX)
2.86
-0.03
(-1.04%)
USD |
NASDAQ |
May 15, 16:00
2.86
0.00 (0.00%)
After-Hours: 20:00
LAVA Therapeutics Gross Profit Margin (Quarterly): 56.37% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 56.37% |
September 30, 2023 | 81.13% |
Date | Value |
---|---|
June 30, 2023 | 53.53% |
March 31, 2023 | 24.02% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
24.02%
Minimum
Mar 2023
81.13%
Maximum
Sep 2023
53.76%
Average
54.95%
Median
Gross Profit Margin (Quarterly) Benchmarks
uniQure NV | -8.73% |
ProQR Therapeutics NV | -- |
Merus NV | -- |
argenx SE | 89.23% |
Pharming Group | 84.91% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -63.41% |
Return on Assets | -34.18% |
Return on Invested Capital | -59.01% |
Profit Margin (Quarterly) | -1.84K% |
Operating Margin (Quarterly) | -1.54K% |
Return on Net Operating Assets | -138.3% |